Background pattern

MOMETASONE MEDE 0.1% CUTANEOUS SOLUTION

Ask a doctor about a prescription for MOMETASONE MEDE 0.1% CUTANEOUS SOLUTION

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use MOMETASONE MEDE 0.1% CUTANEOUS SOLUTION

Introduction

Leaflet: information for the user

Mometasona Mede1 mg/g cutaneous solution EFG

mometasone furoate

Read the entire leaflet carefully before starting to use the medicine, as it contains important information for you.

  • Keep this leaflet, as you may need to read it again.
  • If you have any doubts, consult your doctor or pharmacist.
  • This medicine has been prescribed to you personally and should not be given to others, even if they have the same symptoms, as it may harm them.
  • If you experience side effects, consult your doctor or pharmacist, even if they are side effects not listed in this leaflet. See section 4.

Contents of the leaflet:

  1. What Mometasona Mede is and what it is used for
  2. What you need to know before starting to use Mometasona Mede
  3. How to use Mometasona Mede
  4. Possible side effects
  5. Storage of Mometasona Mede
  6. Package contents and additional information

1. What Mometasona Mede is and what it is used for

This medicine contains mometasone furoate as the active ingredient, which belongs to the group of topical glucocorticoids and acts as an anti-inflammatory and antipruritic in skin conditions.

Mometasona Mede is indicated for the relief of inflammatory and pruritic manifestations (with itching or scratching) of dermatoses that respond to treatment with glucocorticoids, such as psoriasis (a skin disease characterized by scaling) and atopic dermatitis (a chronic skin condition characterized by the appearance of scaly eruptions, accompanied by itching).

2. What you need to know before starting to use Mometasona Mede

Do not use Mometasona Mede

If you are allergic to the active ingredient mometasone furoate, to other corticosteroids, or to any of the other components of this medicine (listed in section 6).

Warnings and precautions

Consult your doctor or pharmacist before starting to use Mometasona Mede.

Be particularly careful with this medicine when treating large body surfaces, when using occlusive dressings, in long-term treatments, or when applying it to the skin of the face or skin folds. Avoid contact with the eyes. In case of accidental contact, wash your eyes with plenty of water.

Contact your doctor if you experience blurred vision or other visual disturbances.

Other medicines and Mometasona Mede

Tell your doctor or pharmacist if you are using or have recently used or may need to use any other medicine, including those purchased without a prescription.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine. Mometasona Mede should be avoided in pregnant or breastfeeding women, except on medical prescription.

Driving and using machines

There are no known data to suggest that the product may affect the ability to drive or operate machinery.

Mometasona Mede contains propylene glycol

This medicine contains 300 mg of propylene glycol per gram of cutaneous solution.

Propylene glycol may cause skin irritation.

This medicine contains propylene glycol; do not use on open wounds or large areas of damaged skin (such as burns) without consulting your doctor or pharmacist first.

3. How to use Mometasona Mede

Follow the administration instructions for this medicine exactly as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.

Your doctor will indicate the duration of treatment with this medicine. Do not stop treatment on your own.

If you think the effect of this medicine is too strong or too weak, tell your doctor or pharmacist.

Mometasona Mede is for cutaneous use (applied to the skin or scalp).

The recommended dose is:

Apply a few drops of Mometasona Mede to the affected areas once a day and gently massage until it disappears.

Do not cover or bandage the treated area unless your doctor has indicated it.

If you use more Mometasona Mede than you should:

If you have used more Mometasona Mede than indicated, consult your doctor or pharmacist immediately.

In case of overdose or accidental ingestion, go to a medical center or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount used.

If you forget to use Mometasona Mede:

Do not use a double dose to make up for forgotten doses; continue with the usual routine, and if you have forgotten many doses, consult your doctor or pharmacist immediately.

If you stop treatment with Mometasona Mede

Avoid sudden cessation of treatment. As with all highly active steroids, treatment should be discontinued gradually.

If you have any other doubts about using this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can have side effects, although not everyone gets them.

The following side effects have been reported and are classified according to their frequency:

Very common: (may affect more than 1 in 10 people) Common: (may affect up to 1 in 10 people).

Uncommon: (may affect up to 1 in 100 people).

Rare: (may affect up to 1 in 1,000 people).

Very rare: (may affect up to 1 in 10,000 people)

Frequency not known: (cannot be estimated from the available data)

Disorders of the skin and subcutaneous tissue:

  • Common: burning, folliculitis (inflammation of hair follicles), acneiform reaction (acne), pruritus, and signs of cutaneous atrophy.
  • Uncommon: papules (protuberances), pustules (lesions on the skin surface characterized by being small, inflamed, filled with pus, and similar to a blister), and itching
  • Rare: irritation, hypertrichosis (excessive hair growth in an area), hypopigmentation (reduction in pigment production), perioral dermatitis (red papules around the mouth), allergic contact dermatitis, skin maceration (excessive loss of the protective cornified layer), secondary infection, striae, and miliaria (lesion related to acne in which small, hard, and static white cysts appear)

Endocrine disorders:

  • Rare: adrenocortical suppression (suppression of steroid hormone secretion)

Ocular disorders:

Frequency not known: blurred vision

If you think any of the side effects you are experiencing is serious or if you notice any side effect not mentioned in this leaflet, tell your doctor or pharmacist.

Reporting side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Medicines and Healthcare Products Agency (AEMPS) website: https://notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Mometasona Mede

Keep this medicine out of the sight and reach of children.

No special storage conditions are required.

Expiry date: Do not use this medicine after the expiry date stated on the label and carton, after EXP. The expiry date is the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Deposit the containers and medicines you no longer need at the Black medical cross inside a circle with a curved arrow indicating a continuous cyclecollection point in your pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medicines you no longer need. This will help protect the environment.

6. Package contents and additional information

Composition of Mometasona Mede

The active ingredient is mometasone furoate. Each gram of cutaneous solution contains 1 milligram of mometasone furoate.

The other components are: isopropyl alcohol, propylene glycol (E-1520), hydroxypropyl cellulose, sodium dihydrogen phosphate dihydrate, phosphoric acid, and purified water.

Appearance of the product and package contents

Mometasona Mede 1 mg/g cutaneous solution is a clear and colorless solution.

This medicine is presented in bottles of 30 and 60 ml of cutaneous solution.

Marketing authorization holder and manufacturer:

Laboratorio Reig Jofré S.A.

Gran Capitán, 10

08970 Sant Joan Despí (Barcelona) Spain

Date of the last revision of this leaflet: October 2020

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es/

About the medicine

How much does MOMETASONE MEDE 0.1% CUTANEOUS SOLUTION cost in Spain ( 2025)?

The average price of MOMETASONE MEDE 0.1% CUTANEOUS SOLUTION in November, 2025 is around 4.98 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.

Alternatives to MOMETASONE MEDE 0.1% CUTANEOUS SOLUTION in other countries

The best alternatives with the same active ingredient and therapeutic effect.

Alternative to MOMETASONE MEDE 0.1% CUTANEOUS SOLUTION in Poland

Dosage form: Cream, 1 mg/g
Active substance: mometasone
Prescription required
Dosage form: Ointment, 1 mg/g
Active substance: mometasone
Marketing authorisation holder (MAH): N.V. Organon
Prescription required
Dosage form: Ointment, 1 mg/g
Active substance: mometasone
Marketing authorisation holder (MAH): Organon Salud, S.L.
Prescription required
Dosage form: Solution, 1 mg/g
Active substance: mometasone
Marketing authorisation holder (MAH): N.V. Organon
Prescription required
Dosage form: Solution, 1 mg/g
Active substance: mometasone
Marketing authorisation holder (MAH): Organon Healthcare GmbH
Prescription required
Dosage form: Solution, 1 mg/g
Active substance: mometasone
Marketing authorisation holder (MAH): Organon Healthcare GmbH
Prescription required

Alternative to MOMETASONE MEDE 0.1% CUTANEOUS SOLUTION in Ukraine

Dosage form: ointment, 1 mg/g, 15 g in a tube
Active substance: mometasone
Dosage form: ointment, 5 g or 15 g in a tube
Active substance: mometasone
Prescription required
Dosage form: cream, 5 g or 15 g in a tube
Active substance: mometasone
Prescription required
Dosage form: ointment, 1 mg/g in 15 g tube
Active substance: mometasone
Manufacturer: Farmzavod El'fa A.T.
Prescription required
Dosage form: cream, 1 mg/g in 15 g or 30 g tube
Active substance: mometasone
Manufacturer: Farmzavod El'fa A.T.
Prescription required
Dosage form: ointment, 0.1% in 15g tube
Active substance: mometasone
Manufacturer: AT "Farmak
Prescription required

Online doctors for MOMETASONE MEDE 0.1% CUTANEOUS SOLUTION

Discuss dosage, side effects, interactions, contraindications, and prescription renewal for MOMETASONE MEDE 0.1% CUTANEOUS SOLUTION – subject to medical assessment and local rules.

5.0(13)
Doctor

Anna Moret

Dermatology18 years of experience

Dr. Anna Moret is a board-certified dermatologist and dermatovenereologist. She specialises in adult and pediatric dermatology, venereology, aesthetic skin care, and general medicine. Her consultations are evidence-based and tailored to each patient’s dermatological needs.

Dr. Moret provides expert evaluation and treatment for:

  • Skin conditions such as eczema, acne, rosacea, dermatitis, and psoriasis.
  • Hair and scalp issues including hair loss, dandruff, and seborrheic dermatitis.
  • Pediatric skin problems — from newborns to adolescents.
  • Sexually transmitted infections (STIs) and dermatovenereology.
  • Aesthetic concerns: skin ageing, non-invasive cosmetic treatments.
  • Skin allergies and hypersensitivity reactions.
  • Mole checks, lesion evaluation, and skin cancer screening.
  • Skincare advice and personalised cosmeceutical routines.

Combining dermatology with general medical knowledge, Dr. Moret offers comprehensive care that addresses both skin health and underlying conditions. She also holds certification from the Canadian Board of Aesthetic Medicine, ensuring an internationally aligned approach to aesthetic dermatology.

CameraBook a video appointment
€55
November 408:15
November 509:00
November 509:30
November 709:00
November 709:30
More times
0.0(3)
Doctor

Alexandra Alexandrova

General medicine8 years of experience

Dr Alexandra Alexandrova is a licensed general medicine doctor in Spain, specialising in trichology, nutrition, and aesthetic medicine. She offers online consultations for adults, combining a therapeutic approach with personalised care for hair, scalp, and overall health.

Areas of expertise:

  • Hair loss in women and men, postpartum hair loss, androgenetic and telogen effluvium.
  • Scalp conditions: seborrheic dermatitis, psoriasis, scalp irritation, dandruff.
  • Chronic conditions: hypertension, diabetes, metabolic disorders.
  • Online trichology consultation: customised treatment plans, nutritional support, hair growth stimulation.
  • Hair loss prevention: hormonal imbalance, stress factors, haircare strategies.
  • Routine health check-ups, prevention of cardiovascular and metabolic diseases.
  • Personalised nutritional advice to improve hair strength, skin health, and hormonal balance.
  • Aesthetic medicine: non-invasive strategies to enhance skin quality, tone, and metabolic wellness.

Dr Alexandrova follows an evidence-based and holistic approach: online consultations with a therapist and trichologist on Oladoctor provide professional support for hair, scalp, and overall health — all from the comfort of your home.

CameraBook a video appointment
€59
November 1310:00
November 1310:30
November 1311:00
November 1311:30
November 2009:00
More times

Get updates and exclusive offers

Be the first to know about new services, marketplace updates, and subscriber-only promos.

Follow us on social media
FacebookInstagram
Logo
Oladoctor
Find a doctor
Doctors by specialty
Services
Choose language
© 2025 Oladoctor. All rights reserved.
VisaMastercardStripe